Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transplantation of Livers of Hepatitis C (HCV) Seropositive Donors to HCV Seronegative Recipients With Subsequent Therapy With Sofosbuvir/Velpatasvir (Epclusa®)

NCT03819322 is registered in ClinicalTrials.gov with Fernanda P Silveira, MD, MS as lead sponsor.

NCT NCT03819322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03819322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transplantation of Livers of Hepatitis C (HCV) Seropositive Donors to HCV Seronegative Recipients With Subsequent Therapy With Sofosbuvir/Velpatasvir (Epclusa®)
Lead sponsor
Fernanda P Silveira, MD, MS
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2019
Completion date
March 17, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, liver transplant